Последствия вап

Рост смертности

  Attributable Mortality
Bekaert 20116 (30 day) 4.40%
Bekaert 20116 (60 day) 5.90%

Увеличение пребывания в клинике

  VAP Hospital LOS Control Hospital LOS Difference
Warren 20032 (p<0.001) 38 13 25
Rello 20023 (p<0.001) 25.5 14 11.5
Kollef 20055 (p<0.001) 23 7.5 15.5

Увеличение затрат на лечение

  VAP Costs Control Costs Difference
Warren 20032 (p<0.001) $70,568 $21,620 $48,948
Rello 20023 (p<0.001) $104,983 $63,689 $41,294
Kollef 20055 (p<0.001) $150,841 $25,218 $125,623

1. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med. 2001;29(12):2303-2309.  View Abstract
2. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31(5):1312-1317. View Abstract
3. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115-2121. View Abstract
4. Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest. 2001;120(2):555-561.  View Abstract
5. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854-3862. View Abstract
6. Bekaert M, Timsit JF, Vansteelandt S, et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011;184(10):1133-1139.  View Abstract
7. Hugonnet S, Eggimann P, Borst F, Maricot P, Chevrolet JC, Pittet D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol. 2004;25(12):1090-1096. View Abstract